SCHEMBL5281970

SCHEMBL5281970

FC(F)(F)c1cccc(-c2ccc(CNCCCNc3nsc4ccccc34)o2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.48
CACNA1G O43497 1/20 0.45
CACNA1B Q00975 1/20 0.45
PRMT1 Q99873 1/20 0.41
EPHX2 P34913 1/20 0.40
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GAA P10253 2/20 0.38
MAPK1 P28482 1/20 0.38
RAB9A P51151 1/20 0.38
SYK P43405 1/20 0.38
HTR6 P50406 3/20 0.37
EGFR P00533 1/20 0.37
ERBB2 P04626 1/20 0.37
FYN P06241 1/20 0.36
CYP1A1 P04798 1/20 0.36
CYP1A2 P05177 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2970668 0.82 KMT2A (0.49) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL13202847 0.82 L3MBTL1 (0.47) CACNA1GCACNA1BALDH1A1KDM4EMEN1
SCHEMBL5243742 0.80 SIGMAR1 (0.47) SIGMAR1CACNA1GCACNA1BPRMT1ALDH1A1
SCHEMBL5279620 0.78 TP53 (0.41) ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2
SCHEMBL13220593 0.74 EPHX2 (0.37) EPHX2SYKHTR1ADRD2
SCHEMBL13202668 0.74 EPHX2 (0.48) EPHX2SYKFYNDRD2
SCHEMBL13202725 0.73 ACHE (0.50) DRD2
SCHEMBL2978519 0.73 ACKR3 (0.46)
SCHEMBL5280682 0.73 SCN8A (0.45) EPHX2KDM4EEGFR
SCHEMBL28623904 0.72 APP (0.57) EPHX2KDM4EMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776847-B2 Benzisothiazoles useful for treating or preventing HCV infection RIGEL PHARMACEUTICALS, INC. (US) 2010-08-17 US disclosed
EP-1853573-A1 BENZISOTHIAZOLES USEFUL FOR TREATING OR PREVENTING HCV INFECTION Rigel Pharmaceuticals, Inc. (US) 2007-11-14 EP disclosed
WO-2006091858-A1 BENZISOTHIAZOLES USEFUL FOR TREATING OR PREVENTING HCV INFECTION RIGEL PHARMACEUTICALS, INC. (US) 2006-08-31 WO disclosed